Danaher Stock Underperforms Healthcare Sector Despite Strong Q3 Results

Danaher Corporation (DHR) is a global science and technology innovator with a market cap of $163 billion. Its shares have declined 10.6% from its 52-week high and underperformed the broader Health Care Select Sector SPDR Fund's (XLV) 16.6% gain over the past three months. Despite this, analysts remain bullish, with a consensus rating of "Strong Buy" and a mean price target of $251.68, a premium of 9.1% to current levels.